Press Releases 2013
Press Releases 2012
Press Releases 2011
Press Releases 2010
Press Releases 2009
Press Releases 2008
Press Releases 2007
Press Releases 2006
Press Releases 2005
Press Releases 2004
Press Releases 2003
10.21.08
Ironwood Presents Positive Phase 2b Study Results for Linaclotide in Patients with Irritable Bowel Syndrome with Constipation
- Data Presented Today at the 16th United European Gastroenterology Week
10.07.08
Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients with Irritable Bowel Syndrome with Constipation
- Data Presented Today at ACG Annual Scientific Meeting
10.06.08
Ironwood and Collaborators Present Preclinical Data Demonstrating that Cyclic GMP Alleviates Intestinal Pain
10.01.08
Ironwood Raises $50 Million to Advance Linaclotide Through Phase 3
09.23.08
Ironwood and Forest to Present Positive Data from Linaclotide Phase 2b IBS-C Study at ACG Annual Scientific Conference
- Comprehensive Phase 3 Clinical Program Initiated
05.20.08
Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results
04.07.08
Microbia Announces Name Change to Ironwood Pharmaceuticals
03.31.08
Microbia Appoints Halley Gilbert as Vice President, General Counsel
03.04.08
Microbia and Forest Laboratories Announce Preliminary Results of Linaclotide Phase 2B Studies
Chronic constipation and IBS-C studies each meet primary endpoint
Lisa Buffington
VP, Corporate Communications
617.374.5103
lbuffington@ironwoodpharma.com
Copyright © 2013, Ironwood Pharmaceuticals, Inc.
All Rights Reserved
|
Privacy Policy
|
Terms of Service
|
Site Design
